Success Metrics

Clinical Success Rate
90.6%

Based on 125 completed trials

Completion Rate
91%(125/138)
Active Trials
20(10%)
Results Posted
26%(32 trials)
Terminated
13(6%)

Phase Distribution

Ph not_applicable
62
30%
Ph phase_3
38
18%
Ph phase_1
29
14%
Ph early_phase_1
3
1%
Ph phase_4
35
17%
Ph phase_2
39
19%

Phase Distribution

32

Early Stage

39

Mid Stage

73

Late Stage

Phase Distribution206 total trials
Early Phase 1First-in-human
3(1.5%)
Phase 1Safety & dosage
29(14.1%)
Phase 2Efficacy & side effects
39(18.9%)
Phase 3Large-scale testing
38(18.4%)
Phase 4Post-market surveillance
35(17.0%)
N/ANon-phased studies
62(30.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.2%

125 of 145 finished

Non-Completion Rate

13.8%

20 ended early

Currently Active

20

trials recruiting

Total Trials

210

all time

Status Distribution
Active(23)
Completed(125)
Terminated(20)
Other(42)

Detailed Status

Completed125
unknown40
Recruiting14
Terminated13
Withdrawn7
Active, not recruiting6

Development Timeline

Analytics

Development Status

Total Trials
210
Active
20
Success Rate
90.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (1.5%)
Phase 129 (14.1%)
Phase 239 (18.9%)
Phase 338 (18.4%)
Phase 435 (17.0%)
N/A62 (30.1%)

Trials by Status

active_not_recruiting63%
completed12560%
enrolling_by_invitation10%
unknown4019%
withdrawn73%
suspended21%
terminated136%
not_yet_recruiting21%
recruiting147%

Recent Activity

Clinical Trials (210)

Showing 20 of 210 trialsScroll for more
NCT03304496Phase 4

Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.

Suspended
NCT07452822Phase 1

Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease

Not Yet Recruiting
NCT07440797Not Applicable

EVALUATION OF THE EFFICACY AND TOLERANCE OF VASHE SOLUTION VERSUS SALINE SOLUTION IN THE TREATMENT OF VENOUS OR MIXED LEG ULCERS PRESENTING INFLAMMATORY SIGNS SUGGESTING HEAVY BACTERIAL LOAD

Not Yet Recruiting
NCT06426550Not Applicable

Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV

Completed
NCT06176248Not Applicable

Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis

Recruiting
NCT06077916Not Applicable

Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy

Completed
NCT06177197Not Applicable

Bronchiolitis Clearance Airways With Seaserum

Recruiting
NCT05569239Phase 2

Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg

Active Not Recruiting
NCT03619538Not Applicable

Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery

Completed
NCT05324748Phase 3

Repeated GON Injections in CCH

Recruiting
NCT00210210Phase 3

Administration of Ketamine to Prevent the Post-operative Pain

Completed
NCT03514537Not Applicable

Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes

Suspended
NCT07029204Early Phase 1

Intralesional Cyclosporine for Alopecia Areata

Recruiting
NCT03142893Phase 1

Hormonal Mechanisms of Sleep Restriction - Axis Study

Active Not Recruiting
NCT04037605Early Phase 1

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

Active Not Recruiting
NCT06784024Not Applicable

Topical Lidocaine vs. Traditional Management in Manual Vacuum Aspiration Pain Management.

Completed
NCT05504967Phase 2

CT Evaluating the Efficacy of Pre-incisional Local Analgesia With Ropivacaine + Dexamethasone in Pain Management After Tonsillectomy

Completed
NCT07117955Not Applicable

Platelet-Rich Plasma for Peyronie's Disease

Recruiting
NCT04512287Phase 2

PRP for Treatment of Peyronie's Disease

Completed
NCT06789510Not Applicable

Treatment of Peyronie's Disease With Platelet-Rich Plasma

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
210